2020
DOI: 10.2174/1381612826666200224112534
|View full text |Cite
|
Sign up to set email alerts
|

Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning

Abstract: An important goal of biomedical research is to translate basic research findings into practical clinical implementation. Despite the advances in the technology used in drug discovery, the development of drugs for central nervous system diseases remains challenging. The failure rate for new drugs targeting important central nervous system diseases is high compared to most other areas of drug discovery. The main reason for the failure is the poor penetration efficacy across the blood-brain barrier. The blood-bra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
32
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3
1

Relationship

4
6

Authors

Journals

citations
Cited by 54 publications
(32 citation statements)
references
References 228 publications
(265 reference statements)
0
32
0
Order By: Relevance
“…The applicability of these systems in drug discovery depends on how well they can predict brain penetration in vivo [ 5 ]. While there are efforts to establish human cell-based BBB models for drug transport studies, no models fulfill all the validation criteria [ 17 ]. Species differences has been described in absolute protein expression levels of transporters in human, monkey, and mouse brain capillaries [ 12 ] confirming previous functional data.…”
Section: Discussionmentioning
confidence: 99%
“…The applicability of these systems in drug discovery depends on how well they can predict brain penetration in vivo [ 5 ]. While there are efforts to establish human cell-based BBB models for drug transport studies, no models fulfill all the validation criteria [ 17 ]. Species differences has been described in absolute protein expression levels of transporters in human, monkey, and mouse brain capillaries [ 12 ] confirming previous functional data.…”
Section: Discussionmentioning
confidence: 99%
“…Although many animal models and non-randomized data on the pleiotropic effects of statins seems promising and the therapeutic efficacy of statins on cardiovascular and cerebrovascular diseases is being established, proper long term clinical trials and results are necessary to evaluate their therapeutic efficacy on cancer. It is also crucially important from the perspective of drug repositioning [239].…”
Section: Discussionmentioning
confidence: 99%
“…First, we compared cell origins. In TEER evaluation, a widely accepted quantitative technique to measure the integrity of tight junction dynamics in cell culture models [ 41 , 42 , 43 ], the AD-MSC coculture group exhibited a significant increase in TEER values compared with the BM-MSC coculture and non-coculture groups. In addition, AD-MSCs are relatively easy to collect, and a large number of cells can be obtained within a short period of time.…”
Section: Discussionmentioning
confidence: 99%